# BIOLIFE SOLUTIONS INC (BLFS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from BIOLIFE SOLUTIONS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/BLFS/mda/fy2025/): filed 2026-02-26; accession 0001628280-26-012294 (https://www.sec.gov/Archives/edgar/data/834365/000162828026012294/blfs-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/BLFS/mda/fy2024/): filed 2025-03-03; accession 0001628280-25-009511 (https://www.sec.gov/Archives/edgar/data/834365/000162828025009511/blfs-20241231.htm)
- [FY 2023 MD&A](/company/BLFS/mda/fy2023/): filed 2024-02-29; accession 0001628280-24-008061 (https://www.sec.gov/Archives/edgar/data/834365/000162828024008061/blfs-20231231.htm)
- [FY 2022 MD&A](/company/BLFS/mda/fy2022/): filed 2023-03-31; accession 0001437749-23-008875 (https://www.sec.gov/Archives/edgar/data/834365/000143774923008875/bioli20221231_10k.htm)
- [FY 2021 MD&A](/company/BLFS/mda/fy2021/): filed 2022-03-31; accession 0001437749-22-007869 (https://www.sec.gov/Archives/edgar/data/834365/000143774922007869/bioli20211231_10k.htm)

Back to /company/BLFS/